Quarterly Earnings

eHealth is ditching its transactional model for lifelong support, but can it win over skeptical consumers and investors in a competitive market?

Pharma giant AbbVie raises its dividend, backed by robust financials and a powerful drug pipeline that signals a thriving post-Humira growth era.

For the tenth straight year, Sprout Social has won G2's Best Software award. See how its AI pivot and deep customer loyalty are redefining social intelligence.

Cloud security leader Zscaler prepares for high-stakes investor conferences, aiming to showcase its financial strength and AI-driven growth strategy.

Clene Inc. faces investors with promising data for ALS and MS, but a looming cash crunch makes its upcoming conference a critical test of survival.

Innoviva prepares for a key investor conference, spotlighting its shift to specialty drugs and navigating questions on its diversified growth strategy.

Reunion Neuroscience hits the investor conference circuit, seeking capital to advance its groundbreaking psychedelic-inspired therapies for depression and anxiety.

The PXM leader surpassed the coveted 'Rule of 40' financial benchmark in 2025, signaling strong growth and profitability as it preps for an AI-driven future.

Benefits giant Alight faces a massive $3.1B annual loss from a goodwill writedown, suspending its dividend to focus on debt reduction and AI innovation.

With two blockbuster cancer drugs driving record revenue, all eyes are on Syndax's upcoming earnings call for its 2026 outlook and growth strategy.

As Signet prepares its Q4 earnings, all eyes are on whether its brand power can overcome cautious consumer spending and set the tone for the luxury market.

Appian flips from a major loss to GAAP profitability in 2025, driven by strong cloud revenue, key AI contracts, and a positive outlook for 2026.

Specialist asset manager Sprott Inc. leverages a volatile market and geopolitical tensions, riding a precious metals boom to record profits and AUM growth.

AS Tallink Grupp's annual profit fell sharply in 2025, a result masked by a strong fourth-quarter rebound fueled by vessel sales and a key accounting change.

Despite a massive accounting-driven net loss, Renault Group's 2025 results reveal robust operational health, sales growth, and a successful EV push.

The precision tech firm posted record Q1 sales of $669M and a 15% jump in adjusted EPS, driven by a 21% surge in its semiconductor-focused segment.

As Cherry Hill Mortgage preps its 2025 results, investors eye dividends and strategy amid high interest rates and a challenging housing market.

Wyndham Hotels & Resorts reports record development but takes a major Q4 loss from a franchisee's insolvency, yet signals confidence with a dividend hike.

As Teladoc faces slowing growth, the virtual care giant adds insurance titan Michael Smith to its board, signaling a push for financial discipline.

Compass Diversified sets its earnings date, putting its post-Lugano strategy and portfolio health under intense scrutiny from investors.